Hyobin LLC recalls Triple SupremeZen Plus 3500, packaged in cardboard blisters containing one capsule per card, Distributed by Yolo Studi
Recalled May 26, 2021 · FDA recall D-0383-2021 · Hyobin
Hazard
Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil. · FDA Class II
Units
300 cards
Sold at
USA Nationwide
Description
Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil.
Product
Triple SupremeZen Plus 3500, packaged in cardboard blisters containing one capsule per card, Distributed by Yolo Studio, Cliffside Park, NJ
Manufacturer(s)
Hyobin LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →